Tang X - Search Results

1

Hydrophobic IR780 encapsulated in biodegradable human serum albumin nanoparticles for photothermal and photodynamic therapy.

Jiang C, Cheng H, Yuan A, Tang X, Wu J, Hu Y. Jiang C, et al. Among authors: tang x. Acta Biomater. 2015 Mar;14:61-9. doi: 10.1016/j.actbio.2014.11.041. Epub 2014 Nov 25. Acta Biomater. 2015. PMID: 25463484

2

Application of near-infrared dyes for tumor imaging, photothermal, and photodynamic therapies.

Yuan A, Wu J, Tang X, Zhao L, Xu F, Hu Y. Yuan A, et al. Among authors: tang x. J Pharm Sci. 2013 Jan;102(1):6-28. doi: 10.1002/jps.23356. Epub 2012 Nov 6. J Pharm Sci. 2013. PMID: 23132644 Review.

3

Novel self-assembly endows human serum albumin nanoparticles with an enhanced antitumor efficacy.

Ding D, Tang X, Cao X, Wu J, Yuan A, Qiao Q, Pan J, Hu Y. Ding D, et al. Among authors: tang x. AAPS PharmSciTech. 2014 Feb;15(1):213-22. doi: 10.1208/s12249-013-0041-3. Epub 2013 Nov 28. AAPS PharmSciTech. 2014. PMID: 24287627 Free PMC article.

4

Self-assembled PEG-IR-780-C13 micelle as a targeting, safe and highly-effective photothermal agent for in vivo imaging and cancer therapy.

Yuan A, Qiu X, Tang X, Liu W, Wu J, Hu Y. Yuan A, et al. Among authors: tang x. Biomaterials. 2015 May;51:184-193. doi: 10.1016/j.biomaterials.2015.01.069. Epub 2015 Feb 19. Biomaterials. 2015. PMID: 25771009

5

Overcome the limitation of hypoxia against photodynamic therapy to treat cancer cells by using perfluorocarbon nanodroplet for photosensitizer delivery.

Tang X, Cheng Y, Huang S, Zhi F, Yuan A, Hu Y, Wu J. Tang X, et al. Biochem Biophys Res Commun. 2017 Jun 3;487(3):483-487. doi: 10.1016/j.bbrc.2017.03.142. Epub 2017 Mar 27. Biochem Biophys Res Commun. 2017. PMID: 28359763

6

Activatable photodynamic destruction of cancer cells by NIR dye/photosensitizer loaded liposomes.

Yuan A, Tang X, Qiu X, Jiang K, Wu J, Hu Y. Yuan A, et al. Among authors: tang x. Chem Commun (Camb). 2015 Feb 25;51(16):3340-2. doi: 10.1039/c4cc09689d. Chem Commun (Camb). 2015. PMID: 25619336

7

Fabrication of a nanocarrier system through self-assembly of plasma protein and its tumor targeting.

Gong G, Zhi F, Wang K, Tang X, Yuan A, Zhao L, Ding D, Hu Y. Gong G, et al. Among authors: tang x. Nanotechnology. 2011 Jul 22;22(29):295603. doi: 10.1088/0957-4484/22/29/295603. Epub 2011 Jun 15. Nanotechnology. 2011. PMID: 21673386

8

Enhanced antitumor efficacy of cisplatin by tirapazamine-transferrin conjugate.

Wu L, Wu J, Zhou Y, Tang X, Du Y, Hu Y. Wu L, et al. Among authors: tang x. Int J Pharm. 2012 Jul 15;431(1-2):190-6. doi: 10.1016/j.ijpharm.2012.04.032. Epub 2012 Apr 15. Int J Pharm. 2012. PMID: 22531857

9

A novel self-assembly albumin nanocarrier for reducing doxorubicin-mediated cardiotoxicity.

Yuan A, Wu J, Song C, Tang X, Qiao Q, Zhao L, Gong G, Hu Y. Yuan A, et al. Among authors: tang x. J Pharm Sci. 2013 May;102(5):1626-35. doi: 10.1002/jps.23455. Epub 2013 Feb 19. J Pharm Sci. 2013. PMID: 23423631

10

L-1416, a novel MDR reversing agent with possible reduced calcium antagonism.

Zhou Z, Tang X, Zhang Y, Hu Z, Wu J, Hu Y. Zhou Z, et al. Among authors: tang x. Pharmacol Rep. 2014 Dec;66(6):1140-7. doi: 10.1016/j.pharep.2014.07.003. Epub 2014 Aug 2. Pharmacol Rep. 2014. PMID: 25443747

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,652 results

Search Page

Filters